Literature DB >> 27172355

The Pathogenesis of ACLF: The Inflammatory Response and Immune Function.

Richard Moreau1.   

Abstract

Although systemic inflammation is a hallmark of acute-on-chronic liver failure (ACLF), its role in the development of this syndrome is poorly understood. Here the author first summarizes the general principles of the inflammatory response. Inflammation can be triggered by exogenous or endogenous inducers. Important exogenous inducers include bacterial products such as pathogen-associated molecular patterns (PAMPs) and virulence factors. Pathogen-associated molecular patterns elicit inflammation through structural feature recognition (using innate pattern-recognition receptors [PRRs]), whereas virulence factors generally trigger inflammation via functional feature recognition. Endogenous inducers are called danger-associated molecular patterns (DAMPs) and include molecules released by necrotic cells and products of extracellular matrix breakdown. Danger-associated molecular patterns use different PRRs. The purpose of the inflammatory response may differ according to the type of stimulus: The aim of infection-induced inflammation is to decrease pathogen burden, whereas the DAMP-induced inflammation aims to promote tissue repair. An excessive inflammatory response can induce collateral tissue damage (a process called immunopathology). However immunopathology may not be the only mechanism of tissue damage; for example, organ failure can develop because of failed disease tolerance. In this review, the author also discusses how general principles of the inflammatory response can help us to understand the development of ACLF in different contexts: bacterial infection, severe alcoholic hepatitis, and cases in which there is no identifiable trigger. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27172355     DOI: 10.1055/s-0036-1583199

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  28 in total

1.  [Red blood cell distribution width is a independent prognostic indicator for mortality in patients with HBV related acute-on-chronic liver failure].

Authors:  Jiao Qin; Li Qiang; Wen Chen; Gang Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-11-30

2.  Patient Frailty Is Independently Associated With the Risk of Hospitalization for Acute-on-Chronic Liver Failure.

Authors:  Shivani Shah; David S Goldberg; David E Kaplan; Vinay Sundaram; Tamar H Taddei; Nadim Mahmud
Journal:  Liver Transpl       Date:  2020-10-28       Impact factor: 5.799

Review 3.  Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure.

Authors:  Tao Zhang; Kewei Sun; Ya Wang; Lei Huang; Ren Lang; Wei Jiang
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-02       Impact factor: 2.586

4.  Neutrophil-to-Lymphocyte Ratio Predicts Death in Acute-on-Chronic Liver Failure Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.

Authors:  Nicolas Moreau; Xavier Wittebole; Yvan Fleury; Patrice Forget; Pierre-François Laterre; Diego Castanares-Zapatero
Journal:  Shock       Date:  2018-04       Impact factor: 3.454

Review 5.  Acute-on-chronic liver failure: an update.

Authors:  Ruben Hernaez; Elsa Solà; Richard Moreau; Pere Ginès
Journal:  Gut       Date:  2017-01-04       Impact factor: 23.059

Review 6.  Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease.

Authors:  Manuel Tufoni; Maurizio Baldassarre; Giacomo Zaccherini; Agnese Antognoli; Paolo Caraceni
Journal:  Curr Hepatol Rep       Date:  2020-07-01

7.  Overexpression of C‑sis inhibits H2O2‑induced Buffalo rat liver cell apoptosis in vitro and alleviates liver injury in a rat model of fulminant hepatic failure.

Authors:  Hao Ding; Zhili Wen
Journal:  Int J Mol Med       Date:  2018-05-17       Impact factor: 4.101

8.  Altered PGE2-EP2 is associated with an excessive immune response in HBV-related acute-on-chronic liver failure.

Authors:  Yunyun Wang; Chao Chen; Jinjin Qi; Fengtian Wu; Jun Guan; Zhi Chen; Haihong Zhu
Journal:  J Transl Med       Date:  2019-03-19       Impact factor: 5.531

9.  Up-regulation of RIP1 and IPS-1 in chronic HBV infected patients.

Authors:  Minoo Safari-Arababadi; Mohammad Hossein Modarressi; Mohammad Kazemi Arababadi
Journal:  Genet Mol Biol       Date:  2019-08-19       Impact factor: 1.771

10.  Non-invasive Biomarkers of Liver Inflammation and Cell Death in Response to Alcohol Detoxification.

Authors:  Manuela G Neuman; Johannes Mueller; Sebastian Mueller
Journal:  Front Physiol       Date:  2021-07-07       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.